Therapeutic Research Protocol Dose: 1.2 2.4 mg (= 4896 clicks) Duration: 12 20 weeks Frequency: Once weekly Cycle Interval: 4 6 weeks off before repeating Goal / Description: Higher-dose protocol used in obesity research to evaluate sustained satiety and adiposity reduction
These are most likely when starting treatment or moving up a dose, and often settle as your body adjusts which is one reason the dose is increased gradually
Your PlexusDx prescription record must include your physician's signature and the medically necessary indication (such as chronic weight management or metabolic syndrome) to satisfy FSA/HSA documentation standards
As with any pharmaceutical product, GLP-1 agonists should not be depended upon as the sole agent to achieve weight loss, but rather viewed as an adjunct to other treatment modalities nutrition, physical activity, sleep, etc
Start your intake Medical Doctors and Licensed Physicians Medical doctors (MDs) hold the broadest authority to prescribe semaglutide across all states and specialties